Consistent with AAV9-mediated BDH1 renal expression, DKD pathology-related fibrosis, inflammation, and apoptosis were substantially reduced by βOHB supplementation (Figure 7F–7H), whereas the expression of downstream targets of NRF2 was elevated (Supplementary Figure 7A). This evidence concerns the gene BDH1 and diabetic kidney disease.